1.Omeprazole-induced ADR:Literature Analysis of 96 Cases
China Pharmacy 2001;0(11):-
OBJECTIVE: To study the condition and the related factors of adverse drug reactions (ADR) occurred in our hospital. METHODS: A total of 75 omeprazole-induced ADR reports (96 cases) retrieved from 1996 to Mar. 2007 published in domestic medical journals were analyzed statistically. RESULTS: Omeprazole-induced ADR were mostly seen in males aged from 41 to 60, but which was independent of sex. The ADR induced by oral administration usually appeared within 3 days to 2 weeks, while those induced by injection were more often seen at 3~5 min or 3 days later. The ADR might involve multi-organs or systems, and their clinical manifestations were various and complicated, chiefly characterized by allergic reactions and hypolekocytosis, or even allergic shock in severe cases. CONCLUSION: ADR induced by omeprazole call for great attention in the clinic.
2.Progress on mitochondrial silence information regulator family in epilepsy.
Feng ZHU ; Yingchun XIANG ; Linghui ZENG
Journal of Zhejiang University. Medical sciences 2021;50(3):403-408
SIRT3, SIRT4 and SIRT5 are located in mitochondria and also known as mitochondrial sirtuins. They play important roles in regulating many cellular functions including cell survival, cell cycle or apoptosis, DNA repair and metabolism. Mitochondrial sirtuins are involved in the protection of mitochondrial integrity and energy metabolism under stress regulating the expression of neurotransmitter receptors, neurotrophins, extracellular matrix proteins and various transcription factors, thus involved in epileptogenesis triggered by both genetic or acquired factors. Here we review research progress on the actions of mitochondrial sirtuin in epilepsy; and discuss the challenges and perspectives of mitochondrial sirtuin as a potential therapeutic target for epilepsy.
Apoptosis
;
Epilepsy/genetics*
;
Humans
;
Mitochondria/genetics*
;
Sirtuin 3
;
Sirtuins
3.Quality analysis of outpatient prescriptions at both township and village levels in two counties of Hubei province
Haomiao LI ; Yingchun CHEN ; Xiang ZHANG ; Zhanchun FENG ; Hongxia GAO ; Jing WANG ; Zhiguo ZHANG ; Juyang XIONG ; Ping LI
Chinese Journal of Hospital Administration 2017;33(5):384-388
Objective To study the quality of outpatient prescriptions for patients of different age groups at both township and village level,for the purpose of evaluating the outcomes and problems of the ongoing healthcare reform at primary levels.Methods 100 outpatient prescriptions of April 2015 were mechanically sampled randomly from two township hospitals and 8 village clinics in counties A and B in Hubei province.These prescriptions were analyzed for the drug count per prescription,percentage of intravenous prescriptions,that of antibiotics,that of hormones and average cost per prescription.Results At the township hospitals,the drug count per prescription(2.02)of county A was less than that of county B(3.26),while the percentage of intravenous prescriptions(30.30%),that of antibiotics(47.98%)and hormones(6.57%)of county A were significantly less than those of county B(50.65%,69.08% and 15.13% respectively).At village clinic level,the percentage of intravenous prescriptions(31.05%)of county A was higher than that of county B(20.34%),the average prescription costs(¥29.28)of county A was less than county B(¥31.45);while in terms of children′s prescriptions,average drug count of county A(2.50)was higher than county B(2.09),and its proportion of antibiotics(65.91%)was higher than county B(45.56%).Conclusions General primary care reform is faced with challenges of poor control of intravenous injection and use of antibiotics,particularly at village clinics and pediatric drug use in terms of prescription quality control.Both township and village levels should strengthen the supervision over the drug suppliers,guide the demand side to rationally use drugs and focus on the reasonableness of the medication of village clinics and children.
4.Preliminary Study on Improvement Effects of Mongolian Medicine Saorilao- 4 Decoction on Specific Pulmonary Fibrosis Model Rats and Its Mechanisms
Wanfu BAI ; Yujian LIU ; Xiang LI ; Peng WANG ; Hong CHANG ; Haimei HAO ; Yingchun BAI ; Quanli LIU ; Songli SHI
China Pharmacy 2021;32(12):1435-1441
OBJECTIVE:To preliminarily investigate the improveme nt effects and mechanism of Mongolian medicine Saorilao-4 decoction on specific pulmonary fibrosis model rats. METHODS :Male SD rats were randomly divided into normal control group ,model group ,positive control group (pirfenidone,0.163 g/kg)and Saorilao- 4 decoction low ,medium and high dose groups (0.899,1.798,3.596 g/kg),8 rats in each group. Except for normal control group ,other groups were given 6 mg/mL bleomycin intratracheally at 5 mg/kg once to induce the specific pulmonary fibrosis model. From the first day after modeling , normal control group and model group were given normal saline intragastrically ,other groups were given corresponding drugs intragastrically,once a day ,10 mL/kg,for 4 weeks. During the experimental period ,the general condition of the rats in each group was observed and the body mass was weighed. Twenty-four h after last medication ,the appearance morphology of rat l ung in each group were observed. The morphological characteristics of lung tissues were observed by HE and Masson staining. ELISA was adopted to determine the activity of SOD and the content of MDA in serum ,the contents of hydroxyproline (HYP),IL-1β,IL-6,hyaluronidase(HA),laminin(LN)precollagen type Ⅲ(PC-Ⅲ)and collagen type Ⅳ(Col-Ⅳ)in lung tissue. RT-PCR was used to determine the mRNA 发。E-mail:bwf007007@sina.com expression of TGF-β 1,Smad3 and Smad 7 in lung tissue. RESULTS:Compared with model group ,the activity ,hair and diet of the rats in each dose group of Saorilao- 4 decoction and positive control group were significant ly improved ,and the body mass after the last administration was significantly increased ; the pathological change of lung and pulmonary fibrosis were significantly improved ,and the activity of SOD in serum was increased significantly. Serum content of MDA (except for Saorilao- 4 decoction medium dose group ),the contents of HYP (except for Saorilao- 4 decoction high dose group ),IL-1β,IL-6,HA,LN,PC-Ⅲ,Col-Ⅳ(except for Saorilao- 4 decoction high dose group)as well as mRNA expression of TGF-β1 and Smad 3 in lung tissue were significantly decreased ;mRNA expression of Smad 7 was significantly increased (P<0.05 or P<0.01). CONCLUSIONS :Saorilao-4 decoction can significantly improve the lung pathological changes ,delay and reverse the progression of pulmonary fibrosis in specific pulmonary fibrosis model rats ,the mechanism of which may be related to the inhibition of inflammatory response , improvement of lipid peroxidation , down-regulation of TGF-β1 and Smad 3 mRNA expression ,and up-regulation of Smad 7 mRNA expression.